印度医学研究理事会非霍奇金淋巴瘤(高级别)管理共识文件
该共识由核心专家委员会制定,针对印度人群高级别非霍奇金淋巴瘤的管理。文件强调准确诊断需结合病史、体检、实验室检查、组织学、免疫组化、细胞遗传学和分子学及影像学检查;分期采用Ann Arbor系统;疗效应在3-4周期后及治疗结束时基于包含和不包含PET的标准进行影像学评估;治疗依据组织学亚型、疾病范围和年龄;复发患者可行大剂量化疗后自体干细胞移植;3D-CRT和IMRT可显著降低周围正常组织剂量;随访为前2年每3-4月一次,随后3年每6月一次,之后每年一次。
要点
- 准确诊断需结合组织学、免疫组化、细胞遗传学和分子学及影像学检查。
- 分期采用Ann Arbor系统,包含临床、血液学、生化、血清学和影像学参数。
- 疗效应在3-4周期后及治疗结束时基于包含和不包含PET的标准进行影像学评估。
核心结论
- 该共识文件由核心专家委员会制定,提出了印度人群高级别非霍奇金淋巴瘤在诊断、分期、疗效评估、治疗和随访方面的管理建议。
研究设计与样本
- 共识文件,基于核心专家委员会提出的印度人群高级别非霍奇金淋巴瘤管理相关指南制定。
诊断标准与关键数值
- 分期采用Ann Arbor系统,包括临床、血液学、生化、血清学和影像学等参数。
- 疗效应在3-4周期后及治疗结束时基于包含和不包含PET的标准进行影像学评估。
临床应用与阅片要点
- 准确诊断需结合详细病史、临床检查、常规实验室检查、高质量组织学切片(肿瘤及骨髓抽吸/活检)、免疫染色、细胞遗传学和分子学研究及影像学检查。
- 治疗依据组织学亚型、疾病范围和患者年龄。
- 大剂量化疗后自体干细胞移植对复发非霍奇金淋巴瘤有效。
- 3D-CRT和IMRT等新技术可显著降低淋巴瘤患者周围正常组织的辐射剂量。
- 随访:前2年每3-4月一次,随后3年每6月一次,之后每年一次。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This consensus document is based on the guidelines related to the management of Non Hodgkin's Lymphoma (High grade) in the Indian population as proposed by the core expert committee. Accurate diagnosis in hematolymphoid neoplasm requires a combination of detailed history,clinical examination, and various investigations including routine laboratory tests, good quality histology section (of tumor and also bone marrow aspirate/biopsy), immunostaining, cytogenetic and molecular studies and radiology investigations. The staging system used for adult high grade lymphomas is based on the Ann Arbor system and includes various parameters like clinical, haematology, biochemistry, serology and radiology. Response should be evaluated with radiological evaluation after 3-4 cycles and at the end of treatment based on criteria including and excluding PET. Treatment of high grade lymphomas is based on histologic subtype, extent of disease, and age of the patient. Autologous stem cell transplantation after high dose chemotherapy is effective in the treatment of relapsed NHL. Newer RT techniques like 3 dimensional conformal radiation therapy (3D-CRT) and intensity modulated radiation therapy (IMRT) can significantly reduce radiation doses to surrounding normal tissues in lymphoma patients. Patients should be followed up every 3 to 4 months for the first 2 years, followed by 6 monthly for the next 3 years and then annually.
引用
- Doval DC, Bhurani D, Nair R, et al. Indian Council of Medical Research Consensus Document for the Management of Non-Hodgkin's Lymphoma (High Grade). Indian J Med Paediatr Oncol. 2017. PMID: 28469337. doi:10.4103/0971-5851.203500
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。